Accès gratuit
Numéro
Med Sci (Paris)
Volume 29, Numéro 12, Décembre 2013
Page(s) 1080 - 1082
Section Nouvelles
DOI http://dx.doi.org/10.1051/medsci/20132912006
Publié en ligne 20 décembre 2013
  1. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008 ; 26 : 677–704. [CrossRef] [PubMed]
  2. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006 ; 443 : 350–354. [CrossRef] [PubMed]
  3. Yokosuka T, Takamatsu M, Kobayashi-Imanishi W, et al. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J Exp Med 2012 ; 209 : 1201–1217. [CrossRef] [PubMed]
  4. Fife BT, Pauken KE, Eagar TN, et al. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat Immunol 2009 ; 10 : 1185–1192. [CrossRef] [PubMed]
  5. Zinselmeyer BH, Heydari S, Sacristan C, et al. PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis. J Exp Med 2013 ; 210 : 757–774. [CrossRef] [PubMed]
  6. Barber DL, Wherry EJ, Masopust D, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006 ; 439 : 682–687. [CrossRef] [PubMed]
  7. Larsen M, Sauce D, Deback C, et al. Exhausted cytotoxic control of Epstein-Barr virus in human lupus. PLoS Pathog 2011 ; 7 : e1002328. [CrossRef] [PubMed]
  8. Sauce D, Larsen M, Abbott RJ, et al. Upregulation of interleukin 7 receptor alpha and programmed death 1 marks an epitope-specific CD8+ T-cell response that disappears following primary Epstein-Barr virus infection. J Virol 2009 ; 83 : 9068–9078. [CrossRef] [PubMed]
  9. Sauce D, Almeida JR, Larsen M, et al. PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status. Aids 2007 ; 21 : 2005–2013. [CrossRef] [PubMed]
  10. Utzschneider DT, Legat A, Fuertes Marraco SA, et al. T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion. Nat Immunol 2013 ; 14 : 603–610. [CrossRef] [PubMed]